Introduction:

COVID-19 generates a wide range of clinical manifestations in general. In patients with rheumatic diseases, in addition to respiratory manifestations, joint, dermatological, general and cardiovascular manifestations, among others, stand out.

Objective:

To identify the cardiovascular manifestations that most frequently occur in patients with rheumatic diseases and COVID-19.

Methods:

A basic, non-experimental research was carried out, with an exploratory, descriptive and explanatory scope. Universe made up of 37 patients with a previous diagnosis of rheumatic disease and a confirmed diagnosis of COVID-19. Directed observation and documentary review were used as research techniques to identify the presence of cardiovascular manifestations in this type of patient.

Results:

Predominance of female patients (59.56%), diagnosed with osteoarthritis (72.97%) and rheumatoid arthritis (72.97%) and with associated comorbidities (83.78%). Hypertension (61.29%) and hypothyroidism (38.71%) were the most frequent comorbidities. 70.27% of the patients presented cardiovascular manifestations, predominantly arterial hypertension (65.38%), rhythm disorders (57.69%) and Raynaud´s syndrome (53.85%). 80.0% of the male patients presented cardiovascular manifestations, as did 80.64% of the cases with rheumatic disease, COVID-19 and associated comorbidities.

Conclusions:

Cardiovascular manifestations occurred with high frequency in rheumatic patients diagnosed with COVID-19; being more frequent in male patients and with associated comorbidities. High blood pressure, rhythm disorders and Raynaud's syndrome were the most frequent.

        · abstract in Spanish     · text in Spanish     · Spanish ( pdf )